...insulin secretion in mice (Ohki-Hamazaki et al. 1997b, Guan et al. 2010, Metzger et al. 2010), and thus, BRS3 has been viewed as a promising
therapeutic target to treat obesity and diabetes in humans (Guan et al. 2010, Majumdar & Weber 2012, Gonzalez et al. 2015).
However, unlike NMBR/GRPR, hu ~~~